ARV-471
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for ARV-471, covering 2024-07-26 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]